Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

IMA Active’s new tablet press machine, Prexima, is designed to deliver higher productivity and efficiency.

IMA Active Unveils New Tablet Press Machine

Nexvet Biopharma, a veterinary biologics developer, secured a dedicated, cGMP biologics manufacturing facility in Tullamore, Ireland, and plans to invest in disposable technology.

Nexvet Secures Biomanufacturing Facility for Veterinary Biologics

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Manufacturers challenge details in new policies designed to promote access to important therapies.

FDA Faces Controversy Over Quality Metrics and Biosimilars

The Krämer KCP10 upward-conveying capsule polisher elevates, polishes, and dedusts capsules.

Upward-Conveying Polisher is Designed for Capsules

Lannett Company agreed to purchase Kremers Urban Pharmaceuticals, the US specialty generic-pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion.

Lannett Expands Generics with Purchase of Kremers Urban

Mumbai-based Cipla agreed to acquire US companies InvaGen and Exelan, giving Cipla US tablet and capsule production capacity, a more diversified portfolio, and market access.

Cipla Acquires US Companies InvaGen and Exelan

Aragen Bioscience has licensed ProteoNic Biotechnology’s 2G UNic recombinant protein production technology, which increases manufacturing efficiency and reduces cost of goods for recombinant biologicals.

Aragen Bioscience Licenses Protein Production Technology

FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper.

FDA Expands Warning on BD Syringes

The agency has set up a workshop on how to demonstrate the benefits of orphan drugs over existing treatments.

EMA Sets Up Workshop on Orphan Drugs

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

After many legal proceedings surrounding the first FDA-approved biosimilar, Zarxio officially launched commercially on Sept. 3, 2015.